World of DTC Marketing

DECEMBER 1, 2021

OPENING: TV is great at creating awareness, but it can also scare patients away if one of your side effects is “may lead to death.” ” I understand that DTC marketers are in love with TV even though it’s becoming less effective. On top of these side effects is the common side effect of diarrhea.

Side effects 210

Side effects Doctors Physicians Leads 210

European Pharmaceutical Review

JANUARY 11, 2024

A major limitation is that these drugs generally do not target the specific causes of neuropathic pain, and their efficacy is reduced when the underlying conditions, like nerve damage, cannot be treated effectively. What are the key current challenges in the development of pain medicines? Internet] NIH. cited 2024Jan].

Medicine 78

Medicine Pharmacology Management Side effects 78

World of DTC Marketing

AUGUST 29, 2022

DTC marketers spend a lot of time and money gaining insights into patients and caregivers. That information should be shared with HCPs and insurers to understand better the barriers and opportunities of treating patients. The research showed that patients wanted to understand how the drug works and the potential side effects.

Side effects 203

Side effects Physicians Insurance Marketing 203

European Pharmaceutical Review

NOVEMBER 14, 2022

Four medicines recommended for approval in the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP)’s latest meeting included a biosimilar for osteoporosis and a novel COVID-19 vaccine. Indication extension recommendations for 11 medicines.

Medicine 80

Medicine Side effects Safety Pharmaceutical 80

MedCity News

AUGUST 12, 2022

Liver complications are a known side effect risk of Zolgensma and other genetic medicines that are delivered by engineered viruses. The two deaths reported following treatment with Novartis’s Zolgensma mark the first fatal cases of acute liver failure associated with the gene therapy.

Side effects 93

Side effects Engineering Patients Medicine 93

European Pharmaceutical Review

DECEMBER 15, 2022

The European Commission (EC) has expanded the marketing authorisation for Dupixent ® (dupilumab) in the European Union (EU), to treat adults with moderate-to-severe prurigo nodularis (PN) who are candidates for systemic therapy, making it the first and only targeted medicine for the condition in Europe and the US.

Medicine 80

Medicine Safety Side effects Patients 80

PM360

JULY 13, 2023

“Drugs don’t work in patients who don’t take them,” C. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. 1 In addition, of patients who began therapy, more than 70% were no longer on their prescribed medication after 12 months. Everett Koop, MD, U.S.

Patients 98

Patients Side effects Insurance Medical 98

European Pharmaceutical Review

JULY 20, 2022

Our research paper, which is being submitted for publication this summer, aims to create an evidence-based medicine (EBM) methodology that can assess this positive impact, to further help regulators determine appropriate risk minimisation measures. ketoconazole – an antifungal medicine. Supporting regulators.

Medicine 78

Medicine Safety Side effects Electronics 78

European Pharmaceutical Review

OCTOBER 31, 2022

The Pharmacovigilance Risk Assessment Committee (PRAC) , the European Medicines Agency (EMA)’s safety board, has confirmed it recommends the withdrawal of Marketing Authorisation Application (MAA) for amfepramone obesity medicines, to prevent more patients being at risk of serious side effects.

Side effects 81

Side effects Medicine Safety Marketing 81

MedCity News

JANUARY 30, 2024

By catching the disease early, patients have a higher chance of receiving successful treatment, and the cost of treatment can be significantly reduced. Personalized treatment plans: Treatment plans can vary widely depending on the type of cancer, the stage and the patient’s overall health.

Side effects 127

Side effects Ethics Medical Patients 127

European Pharmaceutical Review

DECEMBER 7, 2022

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Comirnaty ® , the Pfizer/BioNTech COVID-19 vaccine for infants and children aged six months to four years in Great Britain. The common, expected side effects were within expectations for a vaccine in this age group.

Food and Drug Administration 83

Food and Drug Administration Patients Side effects Medicine 83

World of DTC Marketing

JULY 1, 2021

Pharma websites, more and more, are becoming less relevant when it comes to intent to ask their doctor about a new drug because they too often are hard to read and don’t answer patients’ questions. Patients want to understand better why their insurance company won’t pay for certain medication or why their co-pay has gone up.

Side effects 217

Side effects Doctors Prescription Media 217

European Pharmaceutical Review

MARCH 25, 2024

The Committee for Medicinal Products for Human Use (CHMP) has recommended granting of a marketing authorization for antibiotic combination Emblaveo® (aztreonam-avibactam) for treatment of complicated intra-abdominal and urinary tract infections, hospital-acquired pneumonia and infections caused by certain types of aerobic Gram-negative bacteria.

Side effects 92

Side effects Medicine Safety Patients 92

Clarivate

JUNE 26, 2023

Obtaining the preferences of patients and their caregivers is not a new concept in healthcare. Increasingly, however, industry guidance documents utilize the term ‘patient preference’ in relation to new drug development and benefit-risk assessment. Health technology assessment (HTA) bodies also have some appetite for this information.

Food and Drug Administration 52

Food and Drug Administration Patients Side effects Medicine 52

PM360

JULY 13, 2023

“People adhere to medicines at a scale that should bewilder everyone in healthcare,” exclaims Grace Lomax, Clinical Director of Patient Connect , part of Clarivate. Little wonder 70% of patients with hypertension remain hypertensive and therefore at risk of myocardial infarctions (MIs) and cerebrovascular accidents.

Patients 98

Patients Education Medical Side effects 98

European Pharmaceutical Review

OCTOBER 9, 2023

A new drug, part of a class of chemicals called potassium-channel openers, has demonstrated potential in offering relief to patients with focal epilepsy. Comparatively, patients given a placebo had on average 18 percent fewer seizures during the treatment phase of the trial, which lasted eight weeks.

Side effects 93

Side effects Recruitment Safety Medicine 93

European Pharmaceutical Review

NOVEMBER 24, 2023

Amgen’s new immunotherapeutic agent Tarlatamab has been shown in a Phase II trial to provide sustained anti-tumour activity in 40 percent of the small cell lung cancer patients. The international DeLLphi-301study was investigated as a new anti-cancer treatment option for patients previously considered to be beyond treatment.

Side effects 105

Side effects Patients Medicine Leads 105

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Side effects 98

pharmaphorum

JANUARY 31, 2023

Medication is a staple of modern medicine, with almost 50% of adults in the United States taking at least one prescription medication. This lack of trust in such a crucial industry can lead to decreased compliance, poor treatment adherence, and negative health outcomes for patients. However, the result of non-adherence is consistent.

Patients 52

Patients Pharma Side effects Education 52

Pharmaceutical Technology

JUNE 5, 2023

Results unveiled at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting indicate that some patients with locally advanced rectal cancer can be treated with chemotherapy alone and may not need radiation therapy before surgery. Additionally, the patients had to be candidates for surgery. In the FOLFOX group, 9.1%

Patients 52

Patients Side effects Medicine 52

European Pharmaceutical Review

JANUARY 30, 2023

In its first meeting of 2023, the European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) recommended four new medicines for approval, providing positive opinions for two type 2 diabetes drugs. Ultimately, this can lead to a progressive decrease in mobility and other severe impairments.

Side effects 73

Side effects Medicine Marketing Patients 73

European Pharmaceutical Review

SEPTEMBER 20, 2022

The Heads of Medicines Agencies (HMA) and the European Medicines Agency (EMA) have announced that biosimilar medicines authorised in the European Union (EU) can now be interchanged with their reference medicine or an equivalent biosimilar product. New regulatory guidance could lead to UK biosimilar boom.

Medicine 89

Medicine Side effects Safety Doctors 89

Pharmaceutical Technology

JUNE 1, 2023

The therapy has been recommended as an option to prevent episodic migraines in adult patients, who have between four and 15 migraine attacks per month, and where a minimum of three preventive treatments have previously failed. Up to 145,000 people in England will have the option to choose this treatment.

Side effects 98

Side effects Consulting Education Medicine 98

European Pharmaceutical Review

NOVEMBER 1, 2022

The committee advises that Cibinqo (abrocitinib), Jyseleca (filgotinib), Olumiant (baricitinib), Rinvoq (upadacitinib) and Xeljanz (tofacitinib), used for chronic inflammatory conditions, should have limited distribution to minimise risk of serious side effects such as cardiovascular diseases, blood clots, cancer and serious infections.

Side effects 86

Side effects Distribution Safety Patients 86

World of DTC Marketing

JULY 5, 2022

Imagine a medicine that reduced the death rate of breast cancer and risk of recurrent breast cancer by 50% lowered the risks of colon cancer and type 2 diabetes by two-thirds, and those of heart disease, hypertension, and Alzheimer’s’ disease by 40%. But… Only 23% of Americans Get Enough Exercise.

Insurance 200

Insurance Doctors Side effects Pharma 200

European Pharmaceutical Review

NOVEMBER 3, 2023

The Medicines and Healthcare products Regulatory Agency (MHRA) has authorised Pfizer’s Litfulo (ritlecitinib) for treatment for severe alopecia areata in patients 12 years and older. A hard capsule medicine, Litfulo is recommended to be taken daily as one 50mg oral dose. Results from this pivotal study showed that 13.4

Food and Drug Administration 84

Food and Drug Administration Side effects Medicine Food 84

European Pharmaceutical Review

NOVEMBER 24, 2022

Patients with refractory systemic lupus erythematosus (SLE) were able to go into remission within three months of one small dose of a personalised anti-CD19 CAR T-cell immunotherapy in a clinical study. Every patient remained in remission up to a year. CAR T therapy for systemic lupus erythematosus.

Side effects 105

Side effects Medicine Doctors Patients 105

PharmaTech

AUGUST 3, 2023

Long-acting products, such as Long-Acting Injectables (LAIs) and implantables, have gained significant traction in recent years, revolutionizing patient treatment and medication adherence. By reducing the number of doses required, long-acting products improve patient compliance and eliminate the risk of missed doses.

Side effects 52

Side effects Medical Medicine Patients 52

Pharmaceutical Technology

DECEMBER 7, 2022

On 29 November, the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) warned of some new and potentially serious eye-related side effects associated with Dupixent, an interleukin (IL)-4/13 inhibitor drug used in the treatment of numerous allergic indications such as atopic dermatitis, asthma and nasal polyps.

Side effects 64

Side effects Food and Drug Administration Safety Physicians 64

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Side effects and cost implications.

Side effects 52

Side effects Patients Medical Medicine 52

European Pharmaceutical Review

NOVEMBER 16, 2023

It has been conditionally authorised by the UK Medicines and Healthcare products Regulatory Agency (MHRA) as a gene-editing therapy for certain patients 12 years old and over with sickle-cell disease and transfusion-dependent β-thalassemia. The agency stated that the gene-editing therapy has the potential to offer “life-long” results.

Safety 93

Safety Side effects Medicine Patients 93

World of DTC Marketing

NOVEMBER 5, 2021

Patients want quick fixes, and the idea of losing some weight because of a new drug is enticing to them. In response, the company has been providing six-month waivers to some insured patients that will cap the drug’s out-of-pocket costs at $25 a month, though the long-term picture of coverage is still in flux. Click to Tweet.

Insurance 271

Insurance Side effects Prescription Medical 271

European Pharmaceutical Review

NOVEMBER 18, 2022

The product, produced by biopharma company PTC Therapeutics, is approved for patients 18 months and over. It has been granted marketing authorisation by the Medicines and Healthcare Products Regulatory Agency (MHRA) in Great Britain. The most common side effects observed were initial insomnia, irritability and dyskinesia.

Side effects 126

Side effects Biopharma Safety Patients 126

Medgadget

MAY 26, 2023

Researchers at the Hubrecht Institute in the Netherlands have developed a biobank of cancer organoids using tissue samples obtained from head and neck cancer patients. If so, this would confirm the utility of organoids as a patient proxy for personalized medicine. So far, the team used the biobank to validate tumor biomarkers.

Side effects 94

Side effects Ethics Patients Medicine 94

Referral MD

JULY 10, 2023

These intelligent digital assistants are revolutionizing how healthcare providers interact with patients, boosting engagement, streamlining support services, and enhancing patient experiences. Let’s explore the potential of AI chatbots in the sphere and find out how this technology can benefit healthcare providers and patients.

Patients 74

Patients Healthcare Healthcare Healthcare Provider 74

Pharmaceutical Technology

JUNE 1, 2023

The centre will be established by UK-based technology innovation centre CPI, in collaboration with Medicines Discovery Catapult, the University of Strathclyde, the University of Liverpool, and Imperial College London. The funding is being provided under the agency’s Transforming Medicines Manufacturing programme.

Medicine 97

Medicine Side effects Manufacturing Leads 97

Pharmaceutical Technology

JUNE 19, 2023

The drug has been designed for the selective treatment of liver cancers and for minimising the treatment’s side effects. It is being developed as an orally administrated drug to treat patients with hepatocellular carcinoma (HCC), the most common form of liver cancer.

Food and Drug Administration 52

Food and Drug Administration Side effects Medicine Food 52